State IA
Clinical Trials in Iowa
Recruiting clinical trials with at least one study location in Iowa. Data updated daily from ClinicalTrials.gov.
Top Conditions in Iowa
Malignant Solid Neoplasm (4)Lung Non-Small Cell Carcinoma (2)Melanoma (2)Non-Hodgkin Lymphoma (2)Chronic Lymphocytic Leukemia (2)Malignant Neoplasm (2)Myeloproliferative Neoplasm (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Lymphoblastic Leukemia (2)Acute Myeloid Leukemia (2)Parkinson Disease (2)Atrial Fibrillation (2)
NCT05572073 N/A
Recruiting
Otoferlin Gene-mediated Hearing Loss Natural History Study
Condition
Sensorineural Hearing Loss, Bilateral
Enrollment
150 pts
Location
United States, Australia, Germany
Sponsor
Akouos, Inc.
NCT06110897 N/A
Recruiting
RESISTance Exercise for Depression Trial
Condition
Major Depressive Disorder
Enrollment
200 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT05952024 Phase 2
Recruiting
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients ...
Condition
Diffuse Large B-Cell Lymphoma
Enrollment
80 pts
Location
United States, Brazil, Puerto Rico
Sponsor
AstraZeneca
NCT03942653 Phase 2
Recruiting
Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen...
Condition
Salivary Gland Carcinoma
Enrollment
20 pts
Location
United States
Sponsor
Manish Patel
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT07145229 Phase 2
Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Condition
Acute Gouty Arthritis
Enrollment
380 pts
Location
United States, Australia, China
Sponsor
Atom Therapeutics Co., Ltd
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT06402331 Phase 2
Recruiting
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
Fusion Pharmaceuticals Inc.
NCT06941272 Phase 1, Phase 2
Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
50 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT06384261 Phase 2
Recruiting
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and ...
Condition
Leukemia, Myeloid, Acute
Enrollment
120 pts
Location
United States, Canada, Germany
Sponsor
OncoVerity, Inc.
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT05587569 N/A
Recruiting
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
Condition
Metatarsus Adductus
Enrollment
80 pts
Location
United States
Sponsor
Treace Medical Concepts, Inc.
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT03981575 N/A
Recruiting
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Condition
Myotonic Dystrophy 1
Enrollment
700 pts
Location
United States, Canada, Germany
Sponsor
Virginia Commonwealth Universi
NCT04115241 N/A
Recruiting
Activity Levels in Bone Marrow Transplant Patients
Condition
Bone Marrow Transplant
Enrollment
200 pts
Location
United States
Sponsor
Michael Tomasson
NCT02122562 Phase 2
Recruiting
Ketamine Alcohol (in Treatment-Resistant Depression)
Condition
Magnetic Resonance Imaging
Enrollment
60 pts
Location
United States
Sponsor
Mark Niciu
NCT06665256 Phase 2
Recruiting
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
Condition
Idiopathic Inflammatory Myopathies
Enrollment
123 pts
Location
United States, France, Germany
Sponsor
Novartis Pharmaceuticals
NCT07180537 N/A
Recruiting
Creating Health Course Study for People With Rheumatological Conditions
Condition
Rheumatoid Arthritis
Enrollment
200 pts
Location
United States
Sponsor
Terry L. Wahls
NCT06422923 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral...
Condition
Epilepsy, Temporal Lobe
Enrollment
10 pts
Location
United States
Sponsor
Neurona Therapeutics
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT01429389 N/A
Recruiting
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
Condition
Down Syndrome
Enrollment
2,000 pts
Location
United States, Canada
Sponsor
Sequenom, Inc.
NCT05145127 Phase 3
Recruiting
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Wit...
Condition
Hemophilia A
Enrollment
245 pts
Location
United States, Australia, Canada
Sponsor
Pfizer
NCT05354141 Phase 3
Recruiting
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (...
Condition
Acute Respiratory Distress Syndrome
Enrollment
970 pts
Location
United States
Sponsor
Direct Biologics, LLC